TENORETIC 100 Drug Patent Profile
✉ Email this page to a colleague
When do Tenoretic 100 patents expire, and what generic alternatives are available?
Tenoretic 100 is a drug marketed by Twi Pharms and is included in one NDA.
The generic ingredient in TENORETIC 100 is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenoretic 100
A generic version of TENORETIC 100 was approved as atenolol; chlorthalidone by TWI PHARMS on May 31st, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENORETIC 100?
- What are the global sales for TENORETIC 100?
- What is Average Wholesale Price for TENORETIC 100?
Summary for TENORETIC 100
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 12 |
DailyMed Link: | TENORETIC 100 at DailyMed |
Pharmacology for TENORETIC 100
Drug Class | Thiazide-like Diuretic beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for TENORETIC 100
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TENORETIC 100
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | 3,663,607 | ⤷ Subscribe |
Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | 3,934,032 | ⤷ Subscribe |
Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | 3,836,671 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TENORETIC 100
See the table below for patents covering TENORETIC 100 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 553747 | VERFAHREN ZUR HERSTELLUNG VON ALKANOLAMINDERIVATEN. | ⤷ Subscribe |
Yugoslavia | 193575 | ⤷ Subscribe | |
U.S.S.R. | 452091 | ⤷ Subscribe | |
Yugoslavia | 193375 | ⤷ Subscribe | |
Switzerland | 547257 | VERFAHREN ZUR HERSTELLUNG VON ALKANOLAMINDERIVATEN. | ⤷ Subscribe |
Austria | 305245 | ⤷ Subscribe | |
Czechoslovakia | 153063 | ZPUSOB VYROBY FENOXYPROPANOLAMINU | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
TENORETIC 100 Market Analysis and Financial Projection Experimental
More… ↓